Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Hum Pathol ; 43(12): 2247-54, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22789784

RESUMEN

Though proliferation has repeatedly shown a prognostic role in sarcomas, it has not reached clinical application. We performed a comprehensive evaluation of the prognostic role of 5 proliferation measures in a large series of soft tissue sarcomas of the extremities and the trunk wall. One hundred ninety-six primary soft tissue sarcomas of the extremities and the trunk wall were subjected to DNA flow cytometry for quantification of S-phase fraction and to immunohistochemical evaluation of Ki-67, Top2a, p21, and p27Kip1. In univariate analysis, positive expression of Ki-67 (hazard ratio = 4.5, CI = 1.6-12.1), Top2a (hazard ratio = 2.2, CI = 1.2-3.5) and high S-phase fraction (hazard ratio = 1.8, CI = 1.2-3.7) significantly correlated with risk for metastasis. When combined with currently used prognostic factors, Ki-67, S-phase fraction and Top2a fraction contributed to refined identification of prognostic risk groups. Proliferation, as assessed by expression of Ki-67 and Top2a and evaluation of S-phase fraction and applied to statistical decision-tree models, provides prognostic information in soft tissue sarcomas of the extremity and trunk wall. Though proliferation contributes independently to currently applied prognosticators, its role is particularly strong when few other factors are available, which suggests a role in preoperative decision-making related to identification of high-risk individuals who would benefit from neoadjuvant therapy.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Proliferación Celular , Metástasis Linfática/patología , Sarcoma/patología , Neoplasias de los Tejidos Blandos/patología , Anciano , Antígenos de Neoplasias/metabolismo , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/metabolismo , ADN-Topoisomerasas de Tipo II/metabolismo , Proteínas de Unión al ADN/metabolismo , Femenino , Humanos , Inmunohistoquímica , Antígeno Ki-67/metabolismo , Masculino , Persona de Mediana Edad , Proteínas de Unión a Poli-ADP-Ribosa , Pronóstico , Sarcoma/metabolismo , Neoplasias de los Tejidos Blandos/metabolismo
2.
J Clin Pathol ; 64(8): 689-94, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21653656

RESUMEN

BACKGROUND: Ezrin is a cytoskeletal protein involved in tumour growth and invasion. Ezrin expression has been suggested to play a role in metastasis in paediatric osteosarcoma and rhabdomyosarcoma. AIM: To evaluate the prognostic role of ezrin in a large series of soft tissue sarcoma of the extremities and trunk wall. METHODS: Ezrin expression was evaluated by immunohistochemistry on tissue microarrays from a mixed series of 256 soft tissue sarcomas. The expression patterns were correlated to local recurrence and metastasis as well as to established prognostic factors in soft tissue sarcoma. RESULTS: Increased ezrin expression predicted development of metastasis (HR=1.8, 95% CI 1.1 to 2.8; p=0.007) and local recurrence, also after adjustment for surgical margin (HR=2.4, 95% CI 1.4 to 4.3; p=0.02). Correlations to established prognostic factors showed strong associations between ezrin and necrosis (OR=3.9, p<0.0001) and ezrin and growth pattern (OR=3.1, p=0.03). CONCLUSIONS: Ezrin independently predicts development of local recurrences and metastases in soft tissue sarcomas. The possibility of preoperative evaluation makes ezrin a potential marker for identification of high-risk sarcoma patients who would benefit from neoadjuvant therapy.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Proteínas del Citoesqueleto/metabolismo , Recurrencia Local de Neoplasia/diagnóstico , Sarcoma/diagnóstico , Neoplasias de los Tejidos Blandos/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Extremidades , Femenino , Humanos , Inmunohistoquímica , Masculino , Análisis por Micromatrices , Persona de Mediana Edad , Metástasis de la Neoplasia , Pronóstico , Tórax , Adulto Joven
17.
Lab Invest ; 89(6): 668-75, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19290004

RESUMEN

Soft tissue sarcoma (STS) diagnostics and prognostics are challenging, particularly in highly malignant and pleomorphic subtypes such as undifferentiated pleomorphic sarcoma (UPS) and leiomyosarcoma (LMS). We applied 32K BAC arrays and gene expression profiling to 18 extremity soft tissue LMS and 31 extremity soft tissue UPS with the aim of identifying molecular subtype signatures and genomic prognostic markers. Both the gains/losses and gene expression signatures revealed striking similarities between UPS and LMS, which were indistinguishable using unsupervised hierarchical cluster analysis and significance analysis for microarrays. Gene expression analysis revealed just nine genes, among them tropomyosin beta, which were differentially expressed. Loss of 4q31 (encompassing the SMAD1 locus), loss of 18q22, and tumor necrosis were identified as independent predictors of metastasis in multivariate stepwise Cox regression analysis. Combined analysis applying loss of 4q31 and 18q22 and the presence of necrosis improved the area under receiver operating characteristic curve for metastasis prediction from 0.64 to 0.86. The extensive genetic similarities between extremity soft tissue UPS and LMS suggest a shared lineage of these STS subtypes and the new and independent genetic prognosticators identified hold promise for refined prognostic determination in high-grade, genetically complex STS.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Histiocitoma Fibroso Maligno/metabolismo , Leiomiosarcoma/metabolismo , Liposarcoma/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Cromosomas Humanos/genética , Análisis por Conglomerados , Diagnóstico Diferencial , Dosificación de Gen , Perfilación de la Expresión Génica , Histiocitoma Fibroso Maligno/diagnóstico , Histiocitoma Fibroso Maligno/genética , Humanos , Leiomiosarcoma/diagnóstico , Leiomiosarcoma/genética , Liposarcoma/diagnóstico , Liposarcoma/genética , Persona de Mediana Edad , Invasividad Neoplásica , Análisis de Secuencia por Matrices de Oligonucleótidos , Pronóstico , Estudios Retrospectivos
18.
Fam Cancer ; 8(3): 209-13, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19130300

RESUMEN

Hereditary nonpolyposis colorectal cancer (HNPCC) is primarily linked to colorectal and endometrial cancer, but is associated with a broad tumor spectrum. Though not formally part of the syndrome, occasional sarcomas have been reported in individuals with HNPCC. We used the national Danish HNPCC-register to identify HNPCC families in which sarcomas had been diagnosed. Fourteen sarcomas were identified in families with mutations in MSH2, MSH6, and MLH1. The median age at sarcoma diagnosis was 43 (15-74) years. Soft tissue sarcomas predominated followed by uterine sarcomas and eight histopathological subtypes were represented with recurrent diagnoses of liposarcoma, leiomyosarcoma, and carcinosarcoma. Tumor tissue from eight cases was available for analysis of mismatch-repair (MMR) status using immunohistochemical staining and analysis of microsatellite instability, which revealed MMR defects in six of the eight tumors investigated. This suggests that sarcomas may be part of the HNPCC tumor spectrum and that colorectal cancer should be considered in the family history of sarcoma patients.


Asunto(s)
Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Proteína 2 Homóloga a MutS/genética , Sarcoma/genética , Adolescente , Adulto , Anciano , Neoplasias Colorrectales/genética , Neoplasias Colorrectales Hereditarias sin Poliposis/patología , Reparación de la Incompatibilidad de ADN , Enzimas Reparadoras del ADN/genética , Proteínas de Unión al ADN/genética , Neoplasias Endometriales/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
19.
Genes Chromosomes Cancer ; 47(10): 845-52, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18615675

RESUMEN

Many solid tumors exhibit characteristic gene fusions, which are reflected by balanced translocations at the cytogenetic level. These changes might be useful diagnostic and prognostic tools. In Wilms tumor (WT, nephroblastoma) no fusions genes or recurrent balanced translocations have been described thus far. To screen for cryptic balanced translocations, we have analyzed 17 renal neoplasms, histopathologically classified as WT, by a combination of G-banding, multicolor FISH, and subtelomeric FISH. This approach revealed several submicroscopic chromosomal aberrations and three different seemingly balanced translocations, resulting in a heterozygous deletion of HACE1, an EWSR1/ERG fusion, and an EWSR1/FLI1 fusion, respectively. As EWSR1 rearrangements are known to be a characteristic of Ewing tumors (ET), our findings illustrate the diagnostic problems regarding small cell kidney tumors and strongly argue for the need of adjuvant diagnostic techniques in this group of neoplasms. In summary, our genomic screening approach proved efficient in finding structural chromosomal aberrations. The fact that no recurrent translocations were found in the WTs of this study argues against the presence of a frequent pathognomonic translocation in this disease entity.


Asunto(s)
Aberraciones Cromosómicas , Neoplasias Renales/genética , Translocación Genética , Tumor de Wilms/genética , Adulto , Niño , Preescolar , Bandeo Cromosómico , Cromosomas Humanos/genética , Diagnóstico Diferencial , Humanos , Hibridación Fluorescente in Situ , Lactante , Cariotipificación , Neoplasias Renales/patología , Proteínas de Fusión Oncogénica/genética , Proteína Proto-Oncogénica c-fli-1 , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Neoplásico/genética , Proteína EWS de Unión a ARN , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Telómero/genética , Factores de Transcripción/genética , Células Tumorales Cultivadas , Ubiquitina-Proteína Ligasas/genética , Tumor de Wilms/patología
20.
Int J Cancer ; 123(7): 1657-63, 2008 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-18623080

RESUMEN

We report a population based case-control study of exposure to pesticides as risk factor for non-Hodgkin lymphoma (NHL). Male and female subjects aged 18-74 years living in Sweden were included during December 1, 1999, to April 30, 2002. Controls were selected from the national population registry. Exposure to different agents was assessed by questionnaire. In total 910 (91 %) cases and 1016 (92%) controls participated. Exposure to herbicides gave odds ratio (OR) 1.72, 95% confidence interval (CI) 1.18-2.51. Regarding phenoxyacetic acids highest risk was calculated for MCPA; OR 2.81, 95% CI 1.27-6.22, all these cases had a latency period >10 years. Exposure to glyphosate gave OR 2.02, 95% CI 1.10-3.71 and with >10 years latency period OR 2.26, 95% CI 1.16-4.40. Insecticides overall gave OR 1.28, 95% CI 0.96-1.72 and impregnating agents OR 1.57, 95% CI 1.07-2.30. Results are also presented for different entities of NHL. In conclusion our study confirmed an association between exposure to phenoxyacetic acids and NHL and the association with glyphosate was considerably strengthened.


Asunto(s)
Exposición a Riesgos Ambientales , Linfoma no Hodgkin/inducido químicamente , Plaguicidas/toxicidad , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Femenino , Humanos , Linfoma no Hodgkin/patología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Encuestas y Cuestionarios , Suecia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA